iifl-logo

LIC MF Healthcare Fund Direct G

LIC MF Healthcare Fund Direct G

Fund Name

LIC Mutual Fund

Scheme Name

LIC MF Healthcare Fund Direct G

AMC

LIC Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

08-Feb-2019

Fund Manager

Sudhanshu Asthana

Net Assets (Rs. cr)

92.55

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

LIC MF Healthcare Fund Direct G - Nav Details

Nav Date

:  24-Jul-2026

NAV [Rs.]

:  35.7414

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.

LIC MF Healthcare Fund Direct G- NAV Chart

LIC MF Healthcare Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-1.21
3.36
12.26
19.58
10.03
22.35
11.96
18.84
Category Avg
-1.38
2.77
12.59
20.09
11.17
21.73
14.14
16.79
Category Best
0.08
4.85
16.89
29.02
18.94
25.4
17.51
30.96
Category Worst
-3.71
0.43
6.55
10.95
3.39
18.24
10.59
4.46

LIC MF Healthcare Fund Direct G- Latest Dividends

No Records Found

LIC MF Healthcare Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

500

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.55524369.76
EquityDivi's Lab.Pharmaceuticals & Biotechnology7.17100836.63
EquityApollo HospitalsHealthcare Services6.7772176.26
EquityTorrent Pharma.Pharmaceuticals & Biotechnology6.55131306.06
EquityNeuland Labs.Pharmaceuticals & Biotechnology5.7428595.31
EquityNavin Fluo.Intl.Chemicals & Petrochemicals5.5867165.16
EquityAurobindo PharmaPharmaceuticals & Biotechnology5.30310504.90
EquityZydus Lifesci.Pharmaceuticals & Biotechnology5.11425004.72
EquityFortis Health.Healthcare Services4.45430324.11
EquityGland PharmaPharmaceuticals & Biotechnology3.79140433.50
EquityAster DM Health.Healthcare Services3.18375002.94
EquityGlobal HealthHealthcare Services3.16222522.92
EquityIpca Labs.Pharmaceuticals & Biotechnology3.05166042.82
EquityBioconPharmaceuticals & Biotechnology2.87635002.65
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.86119942.64
EquityMetropolis HealtHealthcare Services2.76473042.55
EquityArtemis MedicareHealthcare Services2.68935292.47
EquityOneSource Speci.Pharmaceuticals & Biotechnology2.67150092.47
EquityAcutaas ChemicalPharmaceuticals & Biotechnology2.4062962.22
EquityMankind PharmaPharmaceuticals & Biotechnology2.3685772.18
EquityAnthem BiosciencPharmaceuticals & Biotechnology2.11253331.95
EquityDr Agarwal's HeaHealthcare Services2.05395761.89
EquityMax HealthcareHealthcare Services2.05167751.89

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
50,329.19
Trustee/s:
LIC Mutual Fund Trustee P, Mr. Pradeep Jagannath Bhi
Chairman:
NA
CEO / MD:
Ravi Kumar Jha, T.S. Ramakrishnan
CIO:
NA
President:
NA
Director/s:
Sanjay Achyutrao Muthal, Praveen Garg, Raghunandan Maluste, Vijay Sharma
Compliance Officer/s:
NA
Investor Service Officer/s:
Srividya Baliga
Fund Manager/s:
Sudhanshu Asthana
Auditors:
S.R. Batliboi LLP

OTHER INFORMATION

Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.